World Health Organization Raises Concern Over Critical Lack of Weight-Loss Medications

Under 10% of people who could benefit from weight-loss injections such as Wegovy have access to them, caution the World Health Organization as it publishes its inaugural guidance on the drugs.

Considering more than one billion individuals worldwide now obese, it is urging more widespread and fairer access to this class of drugs.

According to estimates, more than two billion are projected to be obese by 2030 without intervention.

"The new guidelines recognises that obesity is a long-term condition that can be treated with holistic and ongoing care," stated its chief Tedros Adhanom Ghebreyesus.

Substantial prices, insufficient output, and distribution challenges are major hurdles to widespread availability to the treatments that can assist patients in reducing significant body mass, explains the organization.

Skinny Jab Shortage

Even in the current best projected case, the manufacturing of these medications would only suffice for about 100 million people – fewer than 10% of those who need them, per the health organization.

The advice urges governments and firms to expand availability, via measures like licensing agreements.

Exclusive production rights on a key compound – the core component of a leading brand – is scheduled to end in multiple countries in 2026.

The Way Obesity Drugs Operate

GLP-1 drugs replicate a biological compound to slow digestion, curb appetite and boost satiety so people eat less.

Patients typically begin shedding pounds after several weeks of starting on the weekly injections.

Studies indicates people may regain a significant portion within a year of discontinuing the medication, when their usual appetite come back.

Being overweight or obese raises your likelihood for contracting health problems, such as type 2 diabetes, cardiovascular issues, stroke, and some malignancies.

Excess weight concerns people in countries worldwide and was associated with over three and a half million fatalities worldwide in 2024, per the WHO.